UNSPSC 51111638: Exatecan

This classification denotes a camptothecin analogue with the molecular formula C24H22FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OC71PP0F89, chemically known as 10h,13h-benzo(de)pyrano(3,4:6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1s-trans)- but generally known as exatecan, which bears US NIH Compound Identifier 151115. The term EXATECAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43).

Most nations schedule exatecan under HS 29399900 and SITC 54149. As of Q4 2014, EXATECAN remains the US FDA Preferred Term for this commodity. Exatecan bears US NLM identifiers UMLS ID C0965941 and NCI Concept Code C66720. SMILES: CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O.

The source provided contains no information about state and local procurement activity under UNSPSC 51111638 Exatecan or any recent solicitations, issuing bodies, geographic spread, or contracting activity. The code references a pharmaceutical product but supplies no opportunity data to support a market assessment.

Without recent state and local opportunities in the record, I cannot characterize the active buyer base, scope of work, or geographic concentration under this Commodity code. If procurement activity exists under this code, the source does not document it.